On January 4, 2018, the board of directors of Aduro Biotech, Inc. appointed Jennifer Lew as company's Chief Financial Officer. Ms. Lew, 45, joined Aduro in October 2013 and has served as Aduro's Senior Vice President of Finance since January 2015. Gregory W. Schafer, company's Chief Operating Officer, notified the company on December 29, 2017 that he will resign his position effective March 1, 2018.

In his capacity as Chief Operating Officer, Mr. Schafer had, until the appointment of Ms. Lew as Chief Financial Officer, served as the company's principal financial officer.